Design and evaluation of 2-(4-((2-(2-((2,6-dichloro-3-methylphenyl)amino)benzoyl)hydrazineylidene)methyl)phenoxy)acetic acid as a dual anti-inflammatory and anti-diabetic agent
Computational and experimental findings suggest that compound 7 exhibits favorable drug-like properties and holds promise as a multi-target therapeutic candidate.
Authors
- Hazem A. Ghabbour (ORCID: https://orcid.org/0000-0002-1011-0276)
- Mohamed K. Elgohary (ORCID: https://orcid.org/0000-0002-8269-9526)
- Mahmoud Abdelrahman Alkabbani (ORCID: https://orcid.org/0000-0002-2871-2603)
- Abdulrahman A. Almehizia (ORCID: https://orcid.org/0000-0001-8711-3873)
- Ahmed M. El‐Khatib
- Hatem A. Abdel‐Aziz (ORCID: https://orcid.org/0000-0002-2606-2504)
- Aya Mohamed Ahmed Ibrahim
- Ali Mohamed Alshabi (ORCID: https://orcid.org/0000-0002-9346-2559)
- Mahmoud S. Elkotamy (ORCID: https://orcid.org/0000-0002-8449-1788)
- Ahmed M. Naglah (ORCID: https://orcid.org/0000-0003-4377-5239)
Institutions
- King Saud University (SA)
- MIT University (MK)
- National Water Research Center (EG)
- Najran University (SA)
- Egyptian Russian University (EG)
- RMIT University (AU)
Publication Details
- Journal
- Future Medicinal Chemistry
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1080/17568919.2025.2561543
- Citations
- 1
- Primary Topic
- Synthesis and biological activity
- Type
- article
- Field-Weighted Citation Impact
- 0.94